NCT06652308Completed
Mood Disorders in Multiple Sclerosis Patients
Frequency of Unipolar and Bipolar Mood Disorders in Patients with Multiple Sclerosis: a Retrospective Cohort Study
Source: ClinicalTrials.gov · Last updated 22 Oct 2024
Brief summary (registry, in English)
This study investigates the frequency of unipolar and bipolar mood disorders in patients with multiple sclerosis. MS is a chronic condition that affects the central nervous system, and previous research suggests that mood disorders, such as depression and bipolar disorder, may occur more frequently in MS patients compared to the general population. A retrospective analysis of 85 patients diagnosed with MS was conducted, evaluating lifetime experiences with mood disorders using structured clinical interviews. The goal is to better understand the prevalence of these mood disorders and to raise awareness of the importance of mental health care in patients with MS. The findings highlight that mood disorders, particularly bipolar disorder, are more common in MS patients than previously thought. This information can help healthcare providers improve screening, diagnosis, and treatment for MS patients suffering from mood disorders.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 85 (actual)
- First submitted
- 16 Oct 2024
- Start date
- 1 Jul 2024
- Primary completion date
- 30 Aug 2024
- Lead sponsor
- Islamic Azad University, Sanandaj
- Diseases
- Depression, Bipolar disorder, Multiple sclerosis
- NCT number
- NCT06652308
What you commit to
- Study type: Observational
- Participants enrolled: 85
- From 1 Jul 2024 to the primary completion date, 30 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other Neurological Disorders: Individuals with a diagnosis of any other neurological disease (e.g., epilepsy, Parkinson's disease) will be excluded.
- Head Trauma: History of head trauma that resulted in impaired consciousness or memory loss.
- Seizures: A history of seizures that could affect mood.
- Substance Dependence: A history of substance dependence as per DSM-IV criteria.
- Other Physical Illnesses: Any systemic or physical diseases that could lead to mood symptoms.
Who the study is looking for
- Diagnosis of Multiple Sclerosis: Participants must have a confirmed diagnosis of multiple sclerosis (MS) by a qualified neurologist.
- Age Range: Participants must be between 18 and 65 years of age.
- Informed Consent: Participants must provide informed consent to participate in the study.
- Geographic Location: Participants must reside in Tehran, Iran.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shandong University Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.